ClinicalTrials.govpublic full text
Ipilimumab and GMCSF Immunotherapy for Prostate Cancer
prostate cancer, metastatic castrate resistant prostate cancer, chemotherapy-naïve patients, anti-ctla4 blockade, systemic gm-csf, ipilimumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835667
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.